The Registry of Toxic Effects of Chemical Substances
Benzene, hexachloro - |
UPDATE: May 2005 | MW: 284.76 | MF: C6Cl6 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA adduct
|
Escherichia coli
|
20 µmol/L
|
MUREAV 89,95,1981
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
100 ppm (-enzymatic activation step)
|
RSTUDV 6,161,1976
|
mutation in mammalian somatic cells
|
hamster
lung
|
6 mg/L
|
BLFSBY 39,359,1986
|
other mutation test systems
|
oral | mouse
1 gm/kg
|
MUREAV 343,157,1995
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mammal (species unspecified)
lowest published toxic dose: 27,562 µg/kg (66 day prior to copulation-28 day after birth)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
ENVRAL 31,116,1983
|
oral | monkey
lowest published toxic dose: 910 µg/kg (13 week prior to copulation)
|
Reproductive: Maternal effects: Ovaries, fallopian tubes
|
TOXID9 14,76,1974
|
oral | mouse
lowest published toxic dose: 1 gm/kg (7-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Urogenital system
TXAPA9 35,239,1976
|
oral | mouse
lowest published toxic dose: 600 mg/kg (6-17 day pregnant)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) | Reproductive: Effects on newborn: Biochemical and metabolic
TOLED5 22,223,1984
|
oral | mouse
lowest published toxic dose: 625 mg/kg (8-12 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
TCMUD8 7,7,1987
|
oral | rat
lowest published toxic dose: 556 mg/kg (96 day prior to copulation-21 day after birth)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
TXCYAC 23,33,1982
|
oral | rat
lowest published toxic dose: 40 mg/kg (10-13 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
TXAPA9 29,109,1974
|
oral | rat
lowest published toxic dose: 6,450 mg/kg (1-22 day pregnant/21 day after birth)
|
Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow) | Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
DCTODJ 2,61,1979
|
oral | rat
lowest published toxic dose: 88 mg/kg (70 day male/70 day prior to copulation-22 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
32OAAP -,189,1973
|
oral | rat
lowest published toxic dose: 812 mg/kg (multigenerations)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
AECTCV 5,207,1977
|
oral | rat
lowest published toxic dose: 212 mg/kg (14 day prior to copulation-17 day after birth)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
ARTODN 38,191,1977
|
oral | rat
lowest published toxic dose: 100 mg/kg (14 day prior to copulation)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
TJADAB 45,524,1992
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | hamster
lowest published toxic dose: 1,000 mg/kg/18 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NATUAS 269,510,1977
|
oral | hamster
toxic dose : 3,360 mg/kg/80 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors
TXAPA9 41,155,1977
|
oral | hamster
toxic dose : 3,360 mg/kg/80 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
TXAPA9 41,155,1977
|
oral | mouse
lowest published toxic dose: 6,972 mg/kg/83 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors Blood: Lymphoma including Hodgkin's disease
IJCNAW 23,47,1979
|
oral | rat
lowest published toxic dose: 2,738 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Blood: Leukemia
PAACA3 24,59,1983
|
oral | rat
toxic dose : 5,475 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors
PAACA3 24,59,1983
|
oral | rat
toxic dose : 1,050 mg/kg/30 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
CALEDQ 11,169,1980
|
oral | rat
toxic dose : 6,300 mg/kg/90 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
CRNGDP 6,631,1985
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lethal concentration (50 percent kill): 1,600 mg/m3
|
N/R
|
85GMAT -,72,1982
|
inhalation | cat
lethal concentration (50 percent kill): 1,800 mg/m3/6 hour
|
Behavioral: Tetany | Behavioral: Irritability Behavioral: Alteration of classical conditioning
VCVGK* -,32,1984
|
inhalation | human
lowest published toxic concentration: 0.5 mg/m3/8 hour
|
Eye: Conjunctiva irritation | Behavioral: Somnolence (general depressed activity) Behavioral: Headache
VCVGK* -,33,1984
|
inhalation | mouse
lethal concentration (50 percent kill): 4 gm/m3
|
N/R
|
85GMAT -,72,1982
|
inhalation | rat
lethal concentration (50 percent kill): 3,600 mg/m3
|
N/R
|
85GMAT -,72,1982
|
inhalation | rabbit
lethal concentration (50 percent kill): 1,800 mg/m3
|
N/R
|
85GMAT -,72,1982
|
inhalation | rabbit
lethal concentration (50 percent kill): 1,800 mg/m3/6 hour
|
Behavioral: Tetany | Behavioral: Irritability Behavioral: Alteration of classical conditioning
VCVGK* -,32,1984
|
intraperitoneal | rat
lethal dose : >500 mg/kg
|
N/R
|
NCNSA6 5,18,1953
|
intraperitoneal | rat
lowest published toxic dose: 150 mg/kg
|
N/R
|
JTEHD6 12,223,1983
|
intraperitoneal | rat
lowest published toxic dose: 85.4 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | Biochemical: Metabolism (intermediary): Other
GEPHDP 18,165,1987
|
oral | cat
lethal dose (50 percent kill): 1,700 mg/kg
|
N/R
|
85GMAT -,72,1982
|
oral | guinea pig
lethal dose (50 percent kill): >3 gm/kg
|
N/R
|
PEMNDP 9,469,1991
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): >5 gm/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Change in motor activity (specific assay)
NTIS** PB288-416
|
oral | mammal (species unspecified)
lowest published toxic dose: 500 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,32,1984
|
oral | mouse
lethal dose (50 percent kill): 4 gm/kg
|
N/R
|
85GMAT -,72,1982
|
oral | quail
lethal dose (50 percent kill): >6,400 mg/kg
|
N/R
|
MFLRA3 38,709,1973
|
oral | rat
lethal dose (50 percent kill): 10 gm/kg
|
N/R
|
FMCHA2 -,C163,1991
|
oral | rat
lowest published toxic dose: 1 gm/kg
|
Endocrine: Evidence of thyroid hypofunction
|
BCPCA6 39,817,1990
|
oral | rat
lethal dose (50 percent kill): 3,500 mg/kg
|
Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | Liver: Other changes Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
VCVGK* -,32,1984
|
oral | rat
lowest published toxic dose: 100 mg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOSCF2 76,291,2003
|
oral | rabbit
lethal dose (50 percent kill): 2,600 mg/kg
|
N/R
|
85GMAT -,72,1982
|
unreported route | mammal (species unspecified)
lowest published toxic dose: 10 mg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
VCVGK* -,32,1984
|
unreported route | man
lowest published lethal dose: 220 mg/kg
|
N/R
|
85DCAI 2,73,1970
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lowest published toxic concentration: 20 mg/m3/45 day- intermittent
|
Cardiac: Other changes | Liver: Fatty liver degeneration Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
VCVGK* -,32,1994
|
inhalation | rat
lowest published toxic concentration: 400 mg/m3/4 hour/6 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
VCVGK* -,32,1994
|
inhalation | rat
lowest published toxic concentration: 30 mg/m3/4 hour/17 week- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
VCVGK* -,33,1994
|
inhalation | rabbit
lowest published toxic concentration: 190 mg/m3/20 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
VCVGK* -,32,1994
|
oral | dog
lowest published toxic dose: 36,400 mg/kg/1 year- intermittent
|
Gastrointestinal: Hypermotility, diarrhea | Blood: Changes in erythrocyte (RBC) count Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 40,227,1977
|
oral | hamster
lowest published toxic dose: 4,704 mg/kg/28 week- continuous
|
Endocrine: Changes in thymus weight | Endocrine: Changes in thyroid weight Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
ARTODN 60,343,1987
|
oral | mammal (species unspecified)
lowest published toxic dose: 7,104 mg/kg/30 day- continuous
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Tremor Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTIS** PB288-416
|
oral | monkey
lowest published toxic dose: 3,840 mg/kg/60 day- intermittent
|
Liver: Fatty liver degeneration | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Endocrine: Other changes
TXAPA9 37,433,1976
|
oral | monkey
lowest published toxic dose: 900 mg/kg/90 day- intermittent
|
Reproductive: Maternal effects: Menstrual cycle changes or disorders
|
JJATDK 12,13,1992
|
oral | monkey
lowest published toxic dose: 9.1 mg/kg/13 week- intermittent
|
Reproductive: Maternal effects: Ovaries, fallopian tubes
|
AJVRAH 56,1673,1995
|
oral | monkey
lowest published toxic dose: 480 mg/kg/60 day- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VCVGK* -,33,1994
|
oral | monkey
lowest published toxic dose: 480 mg/kg/60 day- intermittent
|
Reproductive: Maternal effects: Ovaries, fallopian tubes
|
VCVGK* -,33,1994
|
oral | mouse
lowest published toxic dose: 1,512 mg/kg/18 week- continuous
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Metabolism (intermediary): Plasma proteins not involving coagulation
EVHPAZ 39,79,1981
|
oral | mouse
lowest published toxic dose: 842 mg/kg/6 week- continuous
|
Immunological Including Allergic: Decrease in humoral immune response
|
DCTODJ 2,111,1979
|
oral | pig
lowest published toxic dose: 455 mg/kg/13 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in bladder weight | Endocrine: Changes in thyroid weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXAPA9 43,137,1978
|
oral | pig
lowest published toxic dose: 5,414.5 mg/kg/13 week- continuous
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
VCVGK* -,33,1994
|
oral | quail
lowest published toxic dose: 5 gm/kg/10 day- intermittent
|
Liver: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
JTEHD6 15,431,1985
|
oral | quail
lowest published toxic dose: 2,500 mg/kg/5 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
JTEHD6 15,93,1985
|
oral | rat
lowest published toxic dose: 2,022 mg/kg/55 day- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TOLED5 30,71,1986
|
oral | rat
lowest published toxic dose: 1,596 mg/kg/28 day- continuous
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in bladder weight Endocrine: Changes in spleen weight
JTEHD6 11,663,1983
|
oral | rat
lowest published toxic dose: 3,326 mg/kg/15 week- intermittent
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 40,529,1977
|
oral | rat
lowest published toxic dose: 2,100 mg/kg/6 week- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
ARTODN 52,13,1983
|
oral | rat
lowest published toxic dose: 1,729 mg/kg/13 week- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Endocrine: Adrenal cortex hyperplasia Blood: Other changes
TXAPA9 119,181,1993
|
oral | rat
lowest published toxic dose: 250 mg/kg/5 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
JTEHD6 23,311,1988
|
oral | rat
lowest published toxic dose: 1,500 mg/kg/60 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
ARTODN 43,115,1979
|
oral | rat
lowest published toxic dose: 250 mg/kg/5 day- intermittent
|
Endocrine: Evidence of thyroid hypofunction
|
JJATDK 13,79,1993
|
oral | rat
lowest published toxic dose: 280 mg/kg/14 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
BCPCA6 27,361,1978
|
oral | rat
lowest published toxic dose: 30 gm/kg/30 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Change in gonadotropins Endocrine: Effect on menstrual cycle
JAPTO* 20,81,2000
|
oral | rat
lowest published toxic dose: 625 mg/kg/5 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Nutritional and Gross Metabolic: Changes in: Ca
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 350 mg/kg/5 week- intermittent
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 1,750 mg/kg/10 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in kidney weight | Nutritional and Gross Metabolic: Changes in: Ca Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 1,050 mg/kg/15 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in kidney weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 3.5 mg/kg/5 week- intermittent
|
Blood: Other changes | Nutritional and Gross Metabolic: Changes in: Ca
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 700 mg/kg/10 week- intermittent
|
Blood: Other changes | Musculoskeletal: Joints Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 70 mg/kg/10 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Nutritional and Gross Metabolic: Changes in: P
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 105 mg/kg/15 week- intermittent
|
Musculoskeletal: Joints
|
FAATDF 12,242,1989
|
oral | rat
lowest published toxic dose: 1,750 mg/kg/1 week- intermittent
|
Endocrine: Evidence of thyroid hypofunction
|
BCPCA6 39,817,1990
|
oral | rat
lowest published toxic dose: 3,500 mg/kg/1 week- intermittent
|
Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
|
BCPCA6 39,817,1990
|
oral | rat
lowest published toxic dose: 7 gm/kg/1 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Evidence of thyroid hypofunction
BCPCA6 39,817,1990
|
oral | rat
lowest published toxic dose: 56 gm/kg/8 week- intermittent
|
Biochemical: Metabolism (intermediary): Other | Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
BCPCA6 39,817,1990
|
oral | rat
lowest published toxic dose: 59.5 mg/kg/17 week- continuous
|
Liver: Other changes | Blood: Changes in spleen
VCVGK* -,33,1994
|
oral | rat
lowest published toxic dose: 9,450 mg/kg/21 day- continuous
|
Immunological Including Allergic: Increase in humoral response | Liver: Changes in liver weight Endocrine: Changes in spleen weight
TOXID9 72,373,2003
|
oral | rat
lowest published toxic dose: 280 mg/kg/28 day- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 180,233,2002
|
oral | rat
lowest published toxic dose: 20 mg/kg/4 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Other proteins
BCPCA6 65,1495,2003
|
oral | rat
lowest published toxic dose: 20,000 mg/kg/4 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Evidence of thyroid hypofunction
BCPCA6 65,1495,2003
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.002 mg/m3 (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 79,-,2000
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 79,-,2000
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 79,-,2000
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,101,2002
|
TOXICOLOGY REVIEW
|
|
JAMAAP 183,88,1963
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,83,2002
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - FRANCE
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - GERMANY
|
No MAK Established, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 0.5 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.9 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
Carcinogen, SEP2000
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.03 mg/m3, 2003
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: A1753; |
Number of Industries 2; Total Number of Facilities 10; Number of Occupations 12; Total Number of Employees Exposed 1,038; Total Number of Female Employees Exposed 26 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121065/AS)
|
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a fungicide, an additive for pyrotechnic compositions andas wood preservative
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
NTP Carcinogenesis studies; laboratory assigned, October 2000
|
|
REFERENCES:
CODEN
|
|
REFERENCE
32OAAP
|
"Pesticide and the Environment: a Continuing Controversy, Selected Papers Presented and Papers
Reviewed at the 8th Inter-American Conference on Toxicology and Occupational Medicine, Miami,
FL, 1973," Deichmann, W.B., ed., New York, Stratton Intercontinental Medical Book Corp., 1973
|
85DCAI
|
"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C.
Thomas, 1970
|
85GMAT
|
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F.,
et al., Moscow, Centre of International Projects, GKNT, 1982
|
AECTCV
|
Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
|
AJVRAH
|
American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham
Rd., Schaumburg, IL 60196) V.1- 1940-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
BLFSBY
|
Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FMCHA2
|
Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094)
|
GEPHDP
|
General Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523)
V.6- 1975-
|
IJCNAW
|
International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil-
General, 1205 Geneva, Switzerland) V.1- 1966-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JAMAAP
|
JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL
60610) V.1- 1883-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MFLRA3
|
Mededelingen van de Faculteit Landbouwwetenschappen, Rijksuniversiteit Gent. Communications
of the Faculty of Agricultural Sciences, State University of Ghent. (Rijksuniversiteit Gent,
Faculteit Labdbouwwettenschappen, Coupure 653, B-9000, Ghent, Belgium) V.35- 1970-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NCNSA6
|
National Academy of Sciences, National Research Council, Chemical-Biological Coordination
Center, Review. (Washington, DC)
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
PEMNDP
|
Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4
7QG, UK) V.1- 1968-
|
RSTUDV
|
Rivista di Scienza e Technologia degli Alimenti e di Nutrizione Umana. Review of Science and
Technology of Food and Human Nutrition. (Bologna, Italy) V.5-6, 1975-76. Discontinued.
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
|